| Name | JHU395 |
|---|
| Description | JHU395 is an orally-bioavailable and a plasma stable lipophilic glutamine antagonists (GA) prodrug. JHU395 delivers 6-diazo-5-oxo-L-norleucine (DON) to malignant peripheral nerve sheath tumor (MPNST) in vitro and in vivo, and has antitumor activity in MPNST[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H29N3O7 |
|---|---|
| Molecular Weight | 447.48 |